We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

2 exciting momentum stocks with massive potential

These FTSE 250 stars look well placed to soar even higher, says Harvey Jones.

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

These two FTSE 250 stars have seen their share prices rising almost 50% in the past 12 months alone. The future could look just as dazzling.

Full of life

Diploma (LSE: DPLM) is international business supplying specialised technical products and services in the life sciences, seals and controls sectors. And it looks like a rewarding place to be, with the share price up more than 50% in the last 12 months. Over five years it has grown 156%, with its performance chart showing an impressively steady upwards climb. Full marks so far. Can its success continue?

Should you buy Rolls Royce shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Earlier this month, its half-yearly report revealed an impressive 21% rise in revenues and adjusted operating profits to £217.3m and £37.4m respectively, and a 29% rise in profit before tax to £32.9m. Adjusted operating margins held steady at 17.2%, while adjusted earnings per share (EPS) rose 23% to 23.9p.

Full honours

Chief executive Bruce Thompson hailed the group’s strong underlying growth, while acknowledging that it enjoyed a one-off boost from the substantial depreciation in UK sterling. He said the complementary acquisition of Abacus in April has added critical mass and opens up further growth opportunities in healthcare, while the pipeline for acquisitions remains encouraging.

The trading outlook looks positive as City analysts forecast a 15% rise in EPS in the year to 30 September 2017, followed by another 6% in 2018. Revenues and profits also look set to rise strongly. Today’s yield may look low at 1.8% but that is partly a consequence of the stock’s rapid growth. The dividend payout is nicely covered 2.1 times and management is progressive, recently hiking the interim dividend 13% to 7p per share. Investing in Diploma could prove a rewarding education, if you can accept its heady valuation of 26.73 times earnings.

Elementis, Dr Watson

Elementis (LSE: ELM) is up 44% over the past 12 months, although its five-year track record is less impressive than Diploma’s. In June 2015 the speciality chemicals company’s shares plunged 17% to 257p after it issued a profit warning. That was down to the US oil sector slump, which knocked 30% off sales of its additives used in drilling, and weaker Chinese demand for its coatings additives.

Now Elementis is bouncing back, as the US shale industry makes a vibrant comeback and the Chinese economy holds up, with the key manufacturing purchasing managers index showing growth at 51.2 for a second straight month in May.

Chemicals brothers

Elementis is a global operation that employs around 1,400 people in more than 30 worldwide locations, serving customers in North and South America, Europe and Asia Pacific. Last month’s Q1 trading statement reported stronger demand across most of its markets, with further progress expected as it remains on track to increase operating profits.

At 22.7 times earnings it isn’t cheap, although forecast EPS growth of 16% in the 2017 calendar year and 13% in 2018 largely justify that. This reverses falls of 17% and 18% in 2015 and 2016, suggesting that the company is back on track. Its well-covered dividend is forecast to hit 2.5%. The company is in its element right now, although recent volatility shows that it requires healthy demand from a buoyant global economy. Are you feeling bullish?

Harvey Jones has no position in any shares mentioned. The Motley Fool UK has recommended Elementis. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Overjoyed exited middle aged married couple giving high five, finishing doing domestic paperwork together at home. Euphoric happy older mature spouses celebrating successful investment or purchase.
Investing Articles

This beaten-down FTSE 100 dividend share just jumped 11% in a week but still yields almost 5%

Harvey Jones has been highlighting this dividend share opportunity for weeks and suddenly it's showing signs of life. Can the…

Read more »

Investing Articles

Down 53% since May, is this SpaceX-backed UK stock now in the bargain bin?

The Filtronic (LSE:FTC) share price has come crashing back down to earth in recent weeks. Has the selling gone too…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

3,566 shares in this FTSE 100 stalwart earns a £1,443 second income

Stephen Wright sees Unilever's battered share price as an attractive option for investors looking for a second income to consider.

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

3 stocks I’m looking to buy in July

Stephen Wright’s stocks to buy list for July includes a specialist chemicals recovery play, a quiet infrastructure compounder, and an…

Read more »

ISA Individual Savings Account
Investing Articles

How do the government’s latest changes affect your Stocks and Shares ISA?

Stephen Wright explains what the new anti-circumvention rules mean for investors with uninvested cash in their Stocks and Shares ISAs.

Read more »

Businessman hand stacking up arrow on wooden block cubes
Investing Articles

Here’s how much I think Rolls-Royce shares will be worth by the end of 2027

Ken Hall is considering buying Rolls-Royce shares. But just how much further could the stock climb by the end of…

Read more »

Young woman holding up three fingers
Investing Articles

Looking for cheap stocks to buy under £1? Here are 3 quality UK businesses to consider

Always on the hunt for cheap stocks to buy, our writer identifies three appealing UK candidates with strong financials and…

Read more »

Rolls-Royce Hydrogen Test Rig at Loughborough University
Investing Articles

Could small modular reactors take Rolls-Royce shares to the next level?

Rolls-Royce Holdings is investing heavily in the development of mini nuclear power stations. But what could this mean for the…

Read more »